Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older US health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that was key to ending the Covid-19 pandemic. Moderna is seeking Food and Drug Administration (FDA) ap...
Source: [Guardian World](https://www.theguardian.com/us-news/2026/jun/18/fda-flu-vaccine-mrna)